MANAMA: Bahrain has granted emergency use authorisation for the Pfizer/BioNTech Covid-19 vaccine, becoming the second country after Britain to approve it.
It had also approved Sinopharm’s vaccine in November for use by frontline workers.
“The approval of the Pfizer/BioNTech vaccine will add a further important layer to the kingdom’s national Covid-19 response,” National Health Regulatory Authority chief executive Dr Mariam Al Jalahma said yesterday.
She said Bahrain’s comprehensive “Test, Trace and Treat” Covid-19 response strategy, with one of the highest testing rates per capita in the world, has proved effective in breaking the chains of infection, managing down case numbers and saving lives.
Lindsey Dietschi of the Pfizer Gulf Cluster Lead said the “Emergency Use Authorisation in Bahrain marks a historic moment in the fight against Covid-19.
“This authorisation is a goal we have been working towards since we first declared that science will win, and we applaud the National Health Regulatory Authority in Bahrain for their ability to conduct a careful assessment and take timely action to help protect the people of Bahrain.”
&uuid=(email))